IL6 and non-small cell lung carcinoma: The inhibition of the IL6/IL8 - JAK2 signaling can eliminate BRD4 phosphorylation and restore the sensitivity of tumors to BET inhibitors [125].In KRAS - mutated tumors, including non - small - cell lung cancer (NSCLC), an up - regulation of BCL6 has been observed.